Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Poxel closes enrolment in TIMES 2 trial of Imeglimin in Japan
  2. Allergan assesses brazikumab in two clinical programmes for IBD
  3. AstraZeneca reports negative top-line results from TULIP 1 trial
  4. Arrowhead concludes dosing in Phase I ARO-AAT trial
  5. Roche’s Tecentriq threatens BMS’ Opdivo in small cell lung cancer market

Latest Content

September’s top news stories

Emerald Health Pharmaceuticals (EHP) started patient enrolment for its Phase I clinical trial of EHP-101 for the treatment of patients with multiple sclerosis (MS) and scleroderma, and Ra Pharmaceuticals reported positive data from the Phase lb trial examining the pharmacokinetic (PK) of zilucoplan (RA101495 SC) to treat patients with renal impairment. Drugdevelopment-technology.com wraps up the key news stories from September 2018.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top